metyrapone structure
|
Common Name | metyrapone | ||
---|---|---|---|---|
CAS Number | 54-36-4 | Molecular Weight | 226.274 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 384.4±22.0 °C at 760 mmHg | |
Molecular Formula | C14H14N2O | Melting Point | 53-56ºC | |
MSDS | Chinese USA | Flash Point | 189.3±28.8 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of metyraponeMetyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1.Target: CYP11B1Metyrapone is a drug used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). Metyrapone blocks cortisol synthesis by reversibly inhibiting steroid 11β-hydroxylase. This stimulates ACTH secretion, which in turn increases plasma 11-Deoxycortisol levels. |
Name | metyrapone |
---|---|
Synonym | More Synonyms |
Description | Metyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1.Target: CYP11B1Metyrapone is a drug used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). Metyrapone blocks cortisol synthesis by reversibly inhibiting steroid 11β-hydroxylase. This stimulates ACTH secretion, which in turn increases plasma 11-Deoxycortisol levels. |
---|---|
Related Catalog |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 384.4±22.0 °C at 760 mmHg |
Melting Point | 53-56ºC |
Molecular Formula | C14H14N2O |
Molecular Weight | 226.274 |
Flash Point | 189.3±28.8 °C |
Exact Mass | 226.110611 |
PSA | 42.85000 |
LogP | 1.19 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.565 |
Storage condition | Store at +4°C |
Water Solubility | H2O: soluble (sparingly) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P301 + P312 + P330-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn |
Risk Phrases | 22-36/37/38 |
Safety Phrases | 26 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | UC3050000 |
HS Code | 2933399090 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Cytochrome P450-dependent metabolism of caffeine in Drosophila melanogaster.
PLoS ONE 10(2) , e0117328, (2015) Caffeine (1, 3, 7-trimethylxanthine), an alkaloid produced by plants, has antioxidant and insecticide properties that can affect metabolism and cognition. In vertebrates, the metabolites derived from ... |
|
The different roles of glucocorticoids in the hippocampus and hypothalamus in chronic stress-induced HPA axis hyperactivity.
PLoS ONE 9(5) , e97689, (2014) Hypothalamus-pituitary-adrenal (HPA) hyperactivity is observed in many patients suffering from depression and the mechanism underling the dysfunction of HPA axis is not well understood. Chronic stress... |
|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Chem. Res. Toxicol. 23 , 171-83, (2010) Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental... |
Metopyrone |
Metopiron |
Chlorisondamine diiodide |
Mepyrapone |
Metyrapone |
Methopirapone |
Metroprione |
Methapyrapone |
Metyrapon |
Metopirone |
Methopyrinine |
Methopyrone |
2-methyl-1,2-dipyridin-3-ylpropan-1-one |
2-Methyl-1,2-di(pyridin-3-yl)propan-1-one |
1-Propanone, 2-methyl-1,2-di-3-pyridinyl- |
Methopyrapone |
2-Methyl-1,2-di(3-pyridinyl)-1-propanone |
2-méthyl-1,2-dipyridin-3-ylpropan-1-one |
2-Methyl-1,2-dipyridin-3-ylpropan-1-on |